Home / News / World News / Article / Pfizer vax 40 times less effective against Omicron: South African study

Pfizer vax 40 times less effective against Omicron: South African study

The emergence of the Omicron variant of SARS-CoV-2 in November in South Africa has raised concerns that based on the large number of mutations in the spike protein and elsewhere on the virus, this variant will have considerable escape from vaccine elicited immunity

Listen to this article :
Representational Image

Representational Image

Pfizer`s mRNA-based Covid vaccine may be up to 40 times less effective against the new super mutant Omicron variant, a small study led by South African researchers have shown.

The emergence of the Omicron variant of SARS-CoV-2 in November in South Africa has raised concerns that based on the large number of mutations in the spike protein and elsewhere on the virus, this variant will have considerable escape from vaccine elicited immunity.

Trending Stories

Latest Photoscta-pos

Latest VideosView All

Latest Web StoriesView All

Mid-Day FastView All

Advertisement